The Wall Street Journal: TB's Global Resurgence Amplifies U.S. Risk
Multidrug-resistant TB is at epidemic proportions in some parts of the world -- a growing problem the U.S. is surprisingly unprepared for. The U.S. beat back multidrug-resistant tuberculosis in the 1990s. Today, however, a new threat is emerging as drug resistance worsens abroad and far more dangerous strains develop and spread, including some that are all but untreatable with standard drugs (McKay, 12/18).
This is part of Kaiser Health News' Daily Report - a summary of health policy coverage from more than 300 news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Report here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.